mRNA expression of CXCL2, and to lesser degree, CXCL5, but not CXCL1 and CXCL3, had increased on day 28, peaked on day 35, and remained at a similar level until 56 days after AOM and DSS treatment (Figure 2B). Here, CXCL2 is linked to infectious otitis media.